* Victory Square Health Receives an order of 2,000,000 units of Safetest Covid-19 Testing Kits subject to Health Canada approval * Victory Square Health to be exclusive supplier of its proprietary Safetest products to TM Safety Supplies of Canada * This order and potential subsequent orders is subject to Health Canada approval * TM Safety Supplies is a North American supplier of health and safety equipment including PPE protection to some of North America’s largest manufacturers. Based in Toronto, Ontario, TM Safety Supplies clients include Nestle, CIBC Bank, and Sysco to name a fewVANCOUVER, British Columbia, Sept. 27, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the "Company") – a portfolio company of Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that it has entered into a Canadian sales and distribution contract with TM Safety supplies of Canada on September 24, 2020. The order of 2,000,000 Safetest Covid-19 tests has been placed for sale and use in Canada subject to Health Canada approval.This contract can help pave the way for additional sales of the Safetest products and other tests and services offered by Victory Square Health throughout Canada. TM Safety Supplies is a North American supplier of health and safety equipment including PPE protection to some of North America’s largest manufacturers. Based in Toronto, Ontario, TM Safety Supplies clients include Sysco, Nestle, and CIBC Bank, to name a few. (VS Health currently has not entered into a contract or has a direct relationship with Sysco, Nestle, and CIBC Bank.)“This Canadian sales and distribution contract with TM Safety Supplies can pave the road for Victory Square Health to rapidly increase sales and distribution of its testing products in Canada,” said Victory Square Health CEO Felipe Peixoto.TM Safety Supplies provides an array of safety products including sanitization products, gowns, PPE face masks, certified wipes, medical supplies, retail protective equipment including stand alone sanitization stations and much more. TM Safety Products are available for sale across Canada and the United States. www.tmsafetysupplies.comTom Greenberg, TM Safety Supplies CEO said, “TM Safety Supplies is proud to be working with this solid Canadian Company in our joint effort to have millions of Canadian employees be safely and accurately tested for Covid-19 by Victory Square Health’s proprietary testing products after receiving Health Canada Approval” Greenberg continued, “We have met with the VS Health team and believe there are great synergies between our two companies and this initial order will be the start of a long and fruitful relationship between TM Safety Supplies and Victory Square Health.”VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.Check out VictorySquare.com and sign up to VST's official newsletter at www.VictorySquare.com/newsletter.On behalf of the board,Shafin Diamond Tejani Chief Executive Officer Victory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: email@example.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: firstname.lastname@example.orgTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth. The result: rapid scale-up and monetization, with a solid track record of public and private exits.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies. Because we focus on market-ready solutions that scale quickly, we're able to provide strong and stable returns while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.